Top IBD therapies by cost 2014

This statistic displays the costs of the top inflammatory bowel disease drugs worldwide as of 2014. During this time, Janssen Biotech's Remicade, a therapy targeting Crohn's disease and ulcerative collitis costs 31,856 U.S. dollars for the first-year regimen. Approximately, 1 to 1.3 million people currently suffer from IBD in the United States, however, the cause of IBD is currently unknown. IBD occurs in the colon and intestine and can also impact other parts of the body.

Costs of top inflammatory bowel disease drugs as of 2014

Product (company, disease)First-year regimenSubsequent 1-year regimens
---
---
---
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

August 2014

Region

Worldwide

Survey time period

2014

Supplementary notes

UC: ulcerative colitis; CD: Crohn's disease.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Inflammatory bowel disease (IBD) in the U.S. "

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.